Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.29 +0.01 (+3.57%)
At close: Nov 9, 2026 · 4:00 PM EST

Anebulo Pharmaceuticals (ANEB) Invested Capital (2020)

Updated

Anebulo Pharmaceuticals' Invested Capital came in at $30,149 for fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Anebulo Pharmaceuticals (ANEB) Invested Capital (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Anebulo Pharmaceuticals 11.91 Mn -32.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -710,952.00
Sep 30, 2020 -407,075.00
Jun 30, 2020 31,435.00
API Access

Anebulo Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ANEB&period=max&api_key=YOUR_API_KEY